NO platform allows you to synthesize original hybrid molecules consisting of pharmaceutically active compounds (API), prostaglandins (PG) and nitric oxide donors (NO-donors)
Main News
* Gurus successfully completed preclinical trials of asthma treatment drug * Magazine Kommersant published an article about promising multifunctional drug candidates of Gurus BioPharm * Gurus raises $0.7M for preclinical trials of a drug for asthma



Gurus BioPharm, LLC

Russia, 143026, Moscow, territory of Skolkovo Innovation Center, Bolshoy boulevard, 42 building 1

Tel: 8 800 100 69 00


Feedback form

All fields marked with an asterisk are required

On the map